Position in NVS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$35,285
+$3,438 QoQ
Shares Held
231
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank of Jackson Hole Trust holds $9,808,260 across 10 Drug Manufacturers - General names. NVS ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,847 | $3,538,355 | |
| 2 | JNJ |
Johnson & Johnson
|
11,390 | $2,784,171 | |
| 3 | ABBV |
AbbVie Inc.
|
7,298 | $1,587,242 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,067 | $1,210,959 | |
| 5 | PFE |
Pfizer Inc
|
15,439 | $433,527 | |
| 6 | AMGN |
Amgen Inc
|
307 | $108,017 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,340 | $81,271 | |
| 8 | NVS |
Novartis AG
This page
|
231 | $35,285 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,285 | 231 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $31,847 | 231 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,642 | 44 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $5,324 | 44 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $4,905 | 44 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,281 | 44 | Shares | Sole | 2025-01-31 | |
| No filing history on record for this holder in this stock. | ||||||